FI863095A0 - Transmissibla daeggdjursgener associerade med tumoermetastaser. - Google Patents

Transmissibla daeggdjursgener associerade med tumoermetastaser.

Info

Publication number
FI863095A0
FI863095A0 FI863095A FI863095A FI863095A0 FI 863095 A0 FI863095 A0 FI 863095A0 FI 863095 A FI863095 A FI 863095A FI 863095 A FI863095 A FI 863095A FI 863095 A0 FI863095 A0 FI 863095A0
Authority
FI
Finland
Prior art keywords
tumoermetastaser
daeggdjursgener
associerade
transmissible
med
Prior art date
Application number
FI863095A
Other languages
English (en)
Finnish (fi)
Other versions
FI863095A7 (fi
FI863095L (fi
Inventor
Shelly C Bernstein
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of FI863095A7 publication Critical patent/FI863095A7/fi
Publication of FI863095L publication Critical patent/FI863095L/fi
Publication of FI863095A0 publication Critical patent/FI863095A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI863095A 1984-11-30 1985-11-26 Transmissibla daeggdjursgener associerade med tumoermetastaser. FI863095A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
PCT/US1985/002323 WO1986003226A1 (en) 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis

Publications (3)

Publication Number Publication Date
FI863095A7 FI863095A7 (fi) 1986-07-29
FI863095L FI863095L (fi) 1986-07-29
FI863095A0 true FI863095A0 (fi) 1986-07-29

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863095A FI863095A0 (fi) 1984-11-30 1985-11-26 Transmissibla daeggdjursgener associerade med tumoermetastaser.

Country Status (13)

Country Link
EP (1) EP0203970A1 (enrdf_load_html_response)
JP (1) JPS62501399A (enrdf_load_html_response)
AU (1) AU5197986A (enrdf_load_html_response)
DK (1) DK359486A (enrdf_load_html_response)
ES (1) ES8705043A1 (enrdf_load_html_response)
FI (1) FI863095A0 (enrdf_load_html_response)
GR (1) GR852864B (enrdf_load_html_response)
HU (1) HUT41837A (enrdf_load_html_response)
IL (1) IL77157A0 (enrdf_load_html_response)
NO (1) NO863066L (enrdf_load_html_response)
PT (1) PT81584B (enrdf_load_html_response)
WO (1) WO1986003226A1 (enrdf_load_html_response)
ZA (1) ZA859070B (enrdf_load_html_response)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
WO1991005793A1 (en) * 1989-10-18 1991-05-02 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Production and use of human nm23 protein and antibodies therefor
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
AU725186B2 (en) * 1995-11-16 2000-10-05 Baylor College Of Medicine Method for identifying metastatic sequences
JP2000504212A (ja) * 1996-01-10 2000-04-11 ザ・ユニバーシティ・オブ・リバプール 転移誘発性ｄｎａ
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
WO1999022773A2 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
WO1999046385A2 (en) 1998-03-13 1999-09-16 Baylor College Of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
NO863066D0 (no) 1986-07-29
DK359486D0 (da) 1986-07-29
ES8705043A1 (es) 1987-04-16
ZA859070B (en) 1986-07-30
EP0203970A1 (en) 1986-12-10
AU5197986A (en) 1986-06-18
PT81584A (en) 1985-12-01
GR852864B (enrdf_load_html_response) 1986-03-28
FI863095A7 (fi) 1986-07-29
WO1986003226A1 (en) 1986-06-05
FI863095L (fi) 1986-07-29
HUT41837A (en) 1987-05-28
NO863066L (no) 1986-09-29
PT81584B (en) 1987-04-07
DK359486A (da) 1986-07-29
ES549438A0 (es) 1987-04-16
JPS62501399A (ja) 1987-06-11
IL77157A0 (en) 1986-04-29

Similar Documents

Publication Publication Date Title
FI850694L (fi) Mellandestillatfoereningar med foerbaettrade kallrinningsegenskaper.
FI850386A0 (fi) Metalroer foersett med ytbelaeggning.
FI854891L (fi) Arkitektonisk belaeggning med interferensfaerger.
FI840828L (fi) Konditionsstaellning med stoed foer skivstaong.
FI850645L (fi) Olefinpolymerfibrer med laogt deniertal.
FI841689L (fi) Sjaelvtoemmande sopskyffel med laongt skaft.
FI863095A0 (fi) Transmissibla daeggdjursgener associerade med tumoermetastaser.
FI850799L (fi) Med kopplingschuck foersedd automatisk rangeringskoppling.
FI843301A7 (fi) Drivanordning foersedd med motroterande propellrar.
FI853016L (fi) Kopplingsnaetdel med frisvaengande genomstroemningsomvandlare.
FI853582A0 (fi) Digitalt oeverfoeringssystem med adaptiv radiofaeltavstoerning.
FI854093A0 (fi) Boggie foer jaernvaegsvagnar med tippbar stomme.
FI850380A0 (fi) Staellverksskaop med beroeringsskyddat skensystem.
FI854684A0 (fi) Aoterstaellningsanordning med friutloesning.
FI850721A0 (fi) Vakuumstyrsystem med prioritetsbestaemning.
FI851668A0 (fi) Med vaerme aktiverbar tillslutningskolv.
FI851725A7 (fi) Foensterkuvert med tryckkaensligt adressark.
FI844418A0 (fi) Uppvaermningsanordning foer direkteluppvaermda hushaoll med tvaotidstariff.
FI850287A0 (fi) Lunnstropp med krok.
FI844641L (fi) Foerpackningsanordning med flera avdelningar.
FI844585A0 (fi) En med verifikatremsa foersedd foersaendningsfoerpackning.
FI840292A7 (fi) Uppsamlingsmaskin med maongsidig anvaendning.
FI850564L (fi) Pipett med reglerbar volym.
FI841809L (fi) Med spaerr- och shuntdon foersedd vaermeaotervinningsanordning.
FI844550A0 (fi) Med hinderplaot foersedd omroerare.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: WHITEHEAD INSTITUTE FOR BIOMEDICAL